Observe Medical ASA
OSE:OBSRV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.272
0.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Observe Medical ASA
Net Issuance of Common Stock
Observe Medical ASA
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Net Issuance of Common Stock
kr28.5m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Medistim ASA
OSE:MEDI
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lifecare AS
OSE:LIFE
|
Net Issuance of Common Stock
kr42.5m
|
CAGR 3-Years
496%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Observe Medical ASA
Glance View
Observe Medical ASA engages in the business of developing, marketing, and selling innovative medtech products for the global market. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-11-04. The firm has a broad distribution portfolio of medtech devices and disposables, mainly within Urine measurement, Anesthesiology/ICUs and wound care. The firm is recognized for development and distribution of the Sippi automated digital urine system. Sippi is consist of several products like urine temperature catheters fixating devices to use in combination with urine catheters. Another product Biim is s approved for ultrasound imaging of the human body and is specifically used to guide needle and catheter insertions for dialysis and vascular access procedures. Observe Medical ASA is the parent company of its wholly owned subsidiaries, Observe Medical International AS, Observe Medical AB, Observe Medical ApS, Observe Medical Nordic AB and Biim Ultrasound AS.
See Also
What is Observe Medical ASA's Net Issuance of Common Stock?
Net Issuance of Common Stock
28.5m
NOK
Based on the financial report for Dec 31, 2023, Observe Medical ASA's Net Issuance of Common Stock amounts to 28.5m NOK.
What is Observe Medical ASA's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
38%
Over the last year, the Net Issuance of Common Stock growth was -82%. The average annual Net Issuance of Common Stock growth rates for Observe Medical ASA have been -12% over the past three years , 38% over the past five years .
You don't have any saved screeners yet
